Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Robin, Marie; Gras, Luuk; Koster, Lindaet al.
2024 • In British Journal of Haematology, 204, p. 715 - 718
Robin, Marie ; Hôpital Saint Louis, APHP, Université de Paris Cité, Paris, France
Gras, Luuk; EBMT Statistical Unit, Leiden, The Netherlands
Koster, Linda; EBMT Data Office, Leiden, The Netherlands
Gagelmann, Nico ; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
van Gorkom, Gwendolyn; Department of Internal Medicine, Hematology and Oncology, University Hospital Maastricht, Maastricht, The Netherlands
Ederr, Matthias; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
Itälä-Remes, Maija; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
Zuckerman, Tsila ; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Schaap, Nicolaas; Radboud University Medical Centre, Nijmegen, The Netherlands
Drozd-Sokolowska, Joanna; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Raj, Kavita; Department of Haematology, University College London Hospitals NHS Trust, London, UK
Hayden, Patrick J ; Trinity College Dublin, St. James's Hospital, Dublin, Ireland
de Wreede, Liesbeth C; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
Battipaglia, Giorgia ; Hematology Department, Federico II University of Naples, Naples, Italy
Polverelli, Nicola ; Unit of Bone Marrow Transplantation - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Czerw, Tomasz; Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland
Hernandez Boluda, Juan Carlos ; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
Kröger, Nicolaus; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Yakoub-Agha, Ibrahim; Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France
McLornan, Donal P ; Department of Haematology, University College London Hospitals NHS Trust, London, UK
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Pereira A, Bruguera M, Cervantes F, Rozman C. Liver involvement at diagnosis of primary myelofibrosis: a clinicopathological study of twenty-two cases. Eur J Haematol. 1988;40:355–361.
Shorey J, Weinberg MN, Frenkel EP, Fallis BD. Nodular regenerative hyperplasia of the liver in a case of myelofibrosis with extramedullary hematopoiesis and secondary portal venous hypertension. Am J Clin Pathol. 1979;72:122–125.
Tremblay D, Putra J, Vogel A, Winters A, Hoffman R, Schiano TD, et al. The implications of liver biopsy results in patients with myeloproliferative neoplasms being treated with ruxolitinib. Case Rep Hematol. 2019;2019:3294046. https://doi.org/10.1155/2019/3294046
Wong KM, Atenafu EG, Kim D, Kuruvilla J, Lipton JH, Messner H, et al. Incidence and risk factors for early hepatotoxicity and its impact on survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:1589–1599.
Iacobelli S, EBMT Statistical Committee. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2013;48(Suppl 1):S1–S37.
Antithymocyte globulin. In: Jay HH, James EK, editors. LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [accessed 2022 Dec 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK547976/
Kröger N, Holler E, Kobbe G, Bornhäuser M, Schwerdtfeger R, Baurmann H, et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for blood and marrow transplantation. Blood. 2009;114:5264–5270.
Barba P, Martino R, Perez-Simón JA, Fernández-Avilés F, Piñana JL, Valcárcel D, et al. Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2012;47:1343–1349.
Dai H, Penack O, Radujkovic A, Schult D, Majer-Lauterbach J, Blau IW, et al. Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication. Bone Marrow Transplant. 2021;56:1573–1583.
Robin M, Porcher R, Michonneau D, Taurines L, de Fontbrune FS, Xhaard A, et al. Prospective external validation of biomarkers to predict acute graft-versus-host disease severity. Blood Adv. 2022;6:4763–4772.
Spyrou N, Akahoshi Y, Ayuk FA, Holler E, Choe HK, Etra AM, et al. The utility of biomarkers in acute GVHD prognostication. Blood Adv. 2023;7:5152–5155.
Corbacioglu S, Jabbour EJ, Mohty M. Risk factors for development of and progression of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Biol Blood Marrow Transplant. 2019;25:1271–1280.
Ruggiu M, Bedossa P, Rautou PE, Bertheau P, Plessier A, Peffault de Latour R, et al. Utility and safety of liver biopsy in patients with undetermined liver blood test anomalies after allogeneic hematopoietic stem cell transplantation: a monocentric retrospective cohort study. Biol Blood Marrow Transplant. 2018;24(12):2523–1170. https://doi.org/10.1016/j.bbmt.2018.07.037
